{"id":"aluminum-acetate","rwe":[],"_fda":{"id":"082c6441-be48-4466-e063-6394a90ad500","set_id":"082c6441-be47-4466-e063-6394a90ad500","openfda":{"upc":["0851730003003"],"unii":["80EHD8I43D"],"route":["TOPICAL"],"rxcui":["1594642"],"spl_id":["082c6441-be48-4466-e063-6394a90ad500"],"brand_name":["Tricalm Hydrogel"],"spl_set_id":["082c6441-be47-4466-e063-6394a90ad500"],"package_ndc":["71207-221-02"],"product_ndc":["71207-221"],"generic_name":["ALUMINUM ACETATE"],"product_type":["HUMAN OTC DRUG"],"substance_name":["ALUMINUM ACETATE"],"manufacturer_name":["MODULAR THERMAL TECHNOLOGIES LLC DBA LIFE WEAR TECHNOLOGIES"],"application_number":["M016"],"is_original_packager":[true]},"purpose":["Astringent"],"version":"1","warnings":["For external use only. When using this product avoid contact with eyes; if contact occurs, rinse thoroughly with water Stop use and ask a doctor if condition worsens or symptoms last for more than 7 days"],"effective_time":"20231020","active_ingredient":["Aluminum acetate 0.2%"],"inactive_ingredient":["butylene glycol, caprylyl glycol, dehydroacetic acid, ethylhexylglycerin, glycine, hexylene glycol, malic acid, phenoxyethanol, strontium chloride hexahydrate, water, xanthan gum"],"indications_and_usage":["For the temporary relief of minor skin irritations due to: poison ivy poison oak poison sumac insect bites rashes caused by soaps, detergents, cosmetics, or jewelry athlete's foot"],"dosage_and_administration":["adults and children two years of age and older, apply to affected areas as needed or as directed by a physician consult a physician for children under the age of two"],"spl_product_data_elements":["Tricalm Hydrogel Aluminum acetate BUTYLENE GLYCOL GLYCINE HEXYLENE GLYCOL PHENOXYETHANOL ALUMINUM ACETATE ALUMINUM CATION CAPRYLYL GLYCOL DEHYDROACETIC ACID ETHYLHEXYLGLYCERIN MALIC ACID STRONTIUM CHLORIDE HEXAHYDRATE WATER XANTHAN GUM"],"keep_out_of_reach_of_children":["If swallowed, get medical help or contact a Poison Control Center right away."],"package_label_principal_display_panel":["Carton"]},"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Topical","category":"route"},{"label":"Cream","category":"form"},{"label":"Gel","category":"form"},{"label":"Powder","category":"form"},{"label":"Solution","category":"form"},{"label":"Active","category":"status"},{"label":"Skin irritation","category":"indication"},{"label":"Bayer Pharms","category":"company"},{"label":"Approved 1970s","category":"decade"}],"phase":"marketed","safety":{"boxedWarnings":[],"safetySignals":[{"date":"","signal":"HEADACHE","source":"FDA FAERS","actionTaken":"19 reports"},{"date":"","signal":"HYPERSENSITIVITY","source":"FDA FAERS","actionTaken":"16 reports"},{"date":"","signal":"NAUSEA","source":"FDA FAERS","actionTaken":"16 reports"},{"date":"","signal":"THERAPEUTIC PRODUCT EFFECT DECREASED","source":"FDA FAERS","actionTaken":"16 reports"},{"date":"","signal":"CONTRAINDICATED PRODUCT ADMINISTERED","source":"FDA FAERS","actionTaken":"6 reports"},{"date":"","signal":"DRUG INEFFECTIVE","source":"FDA FAERS","actionTaken":"6 reports"},{"date":"","signal":"RHEUMATOID ARTHRITIS","source":"FDA FAERS","actionTaken":"4 reports"},{"date":"","signal":"DRY SKIN","source":"FDA FAERS","actionTaken":"3 reports"},{"date":"","signal":"OFF LABEL USE","source":"FDA FAERS","actionTaken":"3 reports"},{"date":"","signal":"PRURITUS","source":"FDA FAERS","actionTaken":"3 reports"}],"commonSideEffects":[]},"trials":[],"aliases":[],"company":"Bayer","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=ALUMINUM ACETATE","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:17:50.710727+00:00"},"timeline":{"url":"https://en.wikipedia.org/wiki/Aluminum Acetate","method":"deterministic","source":"Wikipedia","rawText":"","confidence":0.8,"sourceType":"wikipedia","retrievedAt":"2026-04-20T00:17:58.222242+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:17:56.324690+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=ALUMINUM ACETATE","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:17:56.676497+00:00"},"administration.route":{"url":"","method":"deterministic","source":"FDA Label","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T00:17:49.253426+00:00"},"safety.boxedWarnings":{"url":"","method":"deterministic","source":"FDA Label (no boxed warning)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T00:17:49.253538+00:00"},"safety.safetySignals":{"url":"https://api.fda.gov/drug/event.json","method":"api_direct","source":"FDA FAERS","rawText":"","confidence":1,"sourceType":"fda_faers","retrievedAt":"2026-04-20T00:17:58.657920+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201015/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:17:57.881710+00:00"},"regulatory.fda_application":{"url":"","method":"deterministic","source":"FDA Label","rawText":"M016","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T00:17:49.253543+00:00"}},"allNames":"domeboro","offLabel":[],"synonyms":["aluminium acetate","acetic acid aluminium salt","aluminum acetate","burow solution"],"timeline":[{"date":"1976-04-30","type":"positive","source":"DrugCentral","milestone":"FDA approval (Bayer Pharms)"}],"brandName":"Domeboro","ecosystem":[{"indication":"Skin irritation","otherDrugs":[{"name":"allantoin","slug":"allantoin","company":""},{"name":"benzalkonium","slug":"benzalkonium","company":""},{"name":"benzethonium","slug":"benzethonium","company":""},{"name":"benzocaine","slug":"benzocaine","company":""}],"globalPrevalence":null}],"mechanism":{"modality":"Small Molecule","explanation":"","oneSentence":"","technicalDetail":"Aluminum acetate in Domeboro acts as a topical astringent, exerting its effects through the formation of a complex with aluminum ions and acetate ions, which helps to reduce inflammation and promote wound healing."},"_wikipedia":{"url":"https://en.wikipedia.org/wiki/Burow's_solution","title":"Burow's solution","extract":"Burow's solution is an aqueous solution of aluminium triacetate. It is available in the U.S.A. as an over-the-counter drug for topical administration, with under the brand name Domeboro .\nThe preparation has astringent and antibacterial properties and may be used to treat a number of skin conditions, including insect bites and stings, rashes caused by poison ivy and poison sumac, swelling, allergies, and bruises. However, its main use is for treatment of otitis, including otomycosis. Rarely, cases have been reported of temporary hearing loss if used to treat otitis when the eardrum is perforated.","wiki_history":"==History==\nThe creator of Burow's solution was Karl August Burow (1809-1874), a military surgeon and anatomist. Burow was also the inventor of some plastic surgery and wound healing techniques which are still in wide use today."},"commercial":{"launchDate":"1976","_launchSource":"DrugCentral (FDA 1976-04-30, BAYER PHARMS)"},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/4998","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=ALUMINUM%20ACETATE","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=ALUMINUM ACETATE","fields":["publications"],"source":"PubMed/NCBI"},{"id":4,"url":"https://en.wikipedia.org/wiki/Burow's_solution","fields":["history","overview"],"source":"Wikipedia"}],"_enrichedAt":"2026-03-30T08:39:42.646571","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:18:00.434721+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[],"genericName":"aluminum acetate","indications":{"approved":[{"name":"Skin irritation","source":"DrugCentral","snomedId":367466007,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT06748404","phase":"PHASE2","title":"TriCalm Hydrogel® in the Treatment of Immunotherapy-Related Pruritus","status":"RECRUITING","sponsor":"University of California, San Diego","startDate":"2025-01-31","conditions":["Immunotherapy-related Pruritus"],"enrollment":28,"completionDate":"2028-12"},{"nctId":"NCT04786873","phase":"PHASE3","title":"A Research Study of How Well Macimorelin Works to Find Out if Children Have a Lack of Growth Hormone and How Safe it is","status":"COMPLETED","sponsor":"AEterna Zentaris","startDate":"2021-11-16","conditions":["Growth Hormone Deficiency"],"enrollment":101,"completionDate":"2024-06-13"},{"nctId":"NCT05399173","phase":"NA","title":"Effect of Laser Acupuncture for Treating Monosymptomatic Nocturnal Enuresis in Adolescent Females","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2022-06-02","conditions":["Non-Specific Urethritis"],"enrollment":60,"completionDate":"2023-09-08"},{"nctId":"NCT03787030","phase":"PHASE3","title":"Application of Vitamin E on Anal Fissure","status":"COMPLETED","sponsor":"Hospital General Universitario Elche","startDate":"2018-12-21","conditions":["Pain"],"enrollment":160,"completionDate":"2019-02-28"},{"nctId":"NCT04258930","phase":"NA","title":"Occlusion vs Standard Treatment for the Treatment of Herpes Zoster","status":"UNKNOWN","sponsor":"Fundación Nacional para la Enseñanza y la Investigación de la Dermatología A.C.","startDate":"2020-02-26","conditions":["Herpes Zoster"],"enrollment":36,"completionDate":"2022-01-31"},{"nctId":"NCT02301052","phase":"PHASE1,PHASE2","title":"Evaluation of Allium Ampeloprasum Spp.Iranicum Cream Effect for the Management of Hemorrhoids Symptoms","status":"UNKNOWN","sponsor":"Shiraz University of Medical Sciences","startDate":"2014-09","conditions":["Hemorrhoids"],"enrollment":75,"completionDate":"2014-12"},{"nctId":"NCT00509886","phase":"NA","title":"Non-prescription Versus Prescription Topical Treatments Versus no Treatment in the Control of Sweating","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2007-06","conditions":["Hyperhidrosis","Excess Sweating"],"enrollment":24,"completionDate":"2007-08"},{"nctId":"NCT02279472","phase":"NA","title":"Optical Coherence Tomography Quantitative Analysis of Changes in Anterior Chamber After Laser Peripheral Lridotomy","status":"UNKNOWN","sponsor":"Second Xiangya Hospital of Central South University","startDate":"2014-10","conditions":["Primary Angle Closure Glaucoma"],"enrollment":40,"completionDate":"2015-01"},{"nctId":"NCT00258245","phase":"PHASE1","title":"Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia","status":"COMPLETED","sponsor":"Barbara Ann Karmanos Cancer Institute","startDate":"2005-05","conditions":["Multiple Myeloma and Plasma Cell Neoplasm"],"enrollment":5,"completionDate":"2008-04"},{"nctId":"NCT00018135","phase":"NA","title":"Parathyroid Hormone Levels in Relation to the Phosphorus Content of Meals","status":"COMPLETED","sponsor":"National Center for Research Resources (NCRR)","startDate":"","conditions":["Renal Failure"],"enrollment":0,"completionDate":""}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"route":"Topical","formulation":"Cream, Gel, Powder, Solution","formulations":[{"form":"CREAM","route":"TOPICAL","productName":"Dermeleve"},{"form":"CREAM","route":"TOPICAL","productName":"Skin protectant"},{"form":"CREAM","route":"TOPICAL","productName":"Dermaleve"},{"form":"GEL","route":"TOPICAL","productName":"DOMEBORO"},{"form":"GEL","route":"TOPICAL","productName":"TriCalm Hydrogel"},{"form":"GEL","route":"TOPICAL","productName":"Astringent"},{"form":"POWDER","route":"TOPICAL","productName":"ZO MEDICAL SURFATROL Astringent"},{"form":"POWDER","route":"TOPICAL","productName":"ZO Skin Health Astringent Solution"},{"form":"SOLUTION","route":"TOPICAL","productName":"TriCalm Extra Strength"},{"form":"SOLUTION","route":"TOPICAL","productName":"Dermeleve Anti Itch Scalp Serum"}]},"crossReferences":{"NUI":"N0000146596","MMSL":"4157","NDDF":"001932","UNII":"80EHD8I43D","VUID":"4018266","VANDF":"4018266","RXNORM":"17609","UMLSCUI":"C0051510","chemblId":"CHEMBL1201015","ChEMBL_ID":"CHEMBL1201015","KEGG_DRUG":"D02843","DRUGBANK_ID":"DB14518","PUBCHEM_CID":"8757","SNOMEDCT_US":"22976006","MESH_SUPPLEMENTAL_RECORD_UI":"C013396"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[{"period":"1976-","companyName":"Bayer Pharms","relationship":"Original Developer"}],"publicationCount":32,"therapeuticAreas":["Infectious Disease"],"biosimilarFilings":[],"originalDeveloper":"Bayer Pharms","recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"approved","companyName":"Bayer","companyId":"bayer","modality":"Small molecule","firstApprovalDate":"1976","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:18:00.434721+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}